Methylprednisolone aceponate
Sold as Advantan scalp, Advantan milk, Macepatan, Adexityl, Vantiglen, Metiderm, Vantaderm, Macepatan fatty, Advantan, Advantan fatty
[(6S,8S,9S,10R,11S,13S,14S,17R)-17-(2-Acetyloxyacetyl)-11-hydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl] propanoate
Drag to rotate. Structure from PubChem CID 63019.
Background
Registration
- Applicants
- 4
- Registrations
- 16
- Schedule source
- SAHPRA documentation
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Adcock ingram limitedCertificate held by Bayer (Pty) Ltd1 of 5 cancelled | Advantan scalp, Advantan milk, Advantan, Advantan fatty | solution, 1 mg / g, 1mg, ointment | 320361, 320362, X0384, X0385, X0386 | S4 | PIPIL |
| Pharmacare limited û woodmeadCertificate held by Pharmacare limited, Pharmacare Ltd | Macepatan, Macepatan fatty | ointment, 1 mg, 10 mg/200 mg/350 mg | 510330, 560423, 590670 | S4 | PIPIL |
| Glenmark Pharmaceuticals South Africa (Pty) Ltd | Adexityl, Vantiglen | emulsion, cream | 540493, 540494, 540495, 540496.495 | Not determined | None |
| Abex Pharmaceutica (Pty) Ltd | Metiderm, Vantaderm | 1 mg, ointment | 580151, 580152.151, 590160, 590161.160 | S4 | PIPIL |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Advantan scalp solution EACH 1,0 ml SOLUTION CONTAINS: METHYLPREDNISOLONE ACEPONATE 1,0 mg | Solution | 32036132/13.4.1/0361 | Cancelled | Not determined | None |
| Advantan milk EACH 100,0 g EMULSION CONTAINS METHYLPREDNISOLONE ACEPONATE 100,0 mg | 1 mg / gEmulsion. | 32036232/13.4.1/0362Approved 8 May 2023 | Registered | Not determined | PIPIL |
| Macepatan ointment EACH 1,0 g OF OINTMENT CONTAINS METHYLPREDNISOLONE ACEPONATE 1,0 mg | Ointment | 51033051/13.4.1/0330 | Registered | Not determined | None |
| Adexityl emulsion EACH 1,0 g EMULSION CONTAINS METHYLPREDNISOLONE ACEPONATE 1,0 mg | Emulsion | 54049354/13.4.1/0493 | Registered | Not determined | None |
| Vantiglen emulsion EACH 1,0 g EMULSION CONTAINS METHYLPREDNISOLONE ACEPONATE 1,0 mg | Emulsion | 54049454/13.4.1/0494.493 | Registered | Not determined | None |
| Adexityl cream EACH 1,0 g CREAM CONTAINS METHYLPREDNISOLONE ACEPONATE 1,0 mg | Cream | 54049554/13.4.1/0495 | Registered | Not determined | None |
| Vantiglen cream EACH 1,0 g CREAM CONTAINS METHYLPREDNISOLONE ACEPONATE 1,0 mg | Cream | 540496.49554/13.4.1/0496.495 | Registered | Not determined | None |
| Macepatan cream EACH 1,0 g CREAM CONTAINS METHYLPREDNISOLONE ACEPONATE 0,1% m/m | 10 mg/200 mg/350 mgCream. | 56042356/13.4.1/0423Approved 23 July 2024 | Registered | S4 | PIPIL |
| Metiderm cream EACH 1,0 g CREAM CONTAINS: METHYLPREDNISOLONE ACEPONATE 1,0 mg | 1 mgCream | 58015158/13.4.1/0151Approved 25 November 2025 | Registered | S4 | PIPIL |
| Vantaderm cream EACH 1,0 g CREAM CONTAINS: METHYLPREDNISOLONE ACEPONATE 1,0 mg | 1 mgCream | 580152.15158/13.4.1/0152.151Approved 25 November 2025 | Registered | S4 | PIPIL |
| Metiderm ointment EACH 1,0 g OF OINTMENT CONTAINS: METHYLPREDNISOLONE ACEPONATE 1,0 mg | Ointment | 59016059/13.4.1/0160 | Registered | Not determined | None |
| Vantaderm ointment EACH 1,0 g OF OINTMENT CONTAINS: METHYLPREDNISOLONE ACEPONATE 1,0 mg | Ointment | 590161.16059/13.4.1/0161.160 | Registered | Not determined | None |
| Macepatan fatty ointment EACH 1,0 g OF OINTMENT CONTAINS: METHYLPREDNISOLONE ACEPONATE 1,0 mg | 1 mgFatty ointment | 59067059/13.4.1/0670Approved 30 June 2026 | Registered | S4 | PIPIL |
| Advantan cream EACH 1 g CREAM CONTAINS METHYLPREDNISOLONE ACEPONATE 1 mg | 1mgCream. Ointment. Fatty ointment | X0384X/13.4.1/384Approved 8 May 1992 | Registered | S4 | PI |
| Advantan ointment EACH 1 g OINTMENT CONTAINS METHYLPREDNISOLONE ACEPONATE 1 mg | Ointment | X0385X/13.4.1/385 | Registered | Not determined | None |
| Advantan fatty ointment EACH 1 g OINTMENT CONTAINS METHYLPREDNISOLONE ACEPONATE 1 mg | Ointment | X0386X/13.4.1/386 | Registered | Not determined | None |
Regulatory status
Where S4 sits on the scale
Prescription-only medicine.
Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S4, read from the product's PI-PIL leaflet.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.